A real challenge: Primary PCI on an Unprotected Left Main Coronary Culprit Lesion

Original title: A Systematic Review and Meta-Analysis on Primary Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Culprit Lesion in the setting of Acute Myocardial Infarction Reference: Marije M. Vis et al. J Am Coll Cardiol Intv 2013;6:317–24

Acute myocardial infarction with a significantly compromised unprotected left main coronary artery culprit lesion is relatively rare (4% to 7%), but presents high mortality rates. Until now, there are no randomized studies on this issue; this is why the meta analysis included 13 cohort studies on unprotected left main as the infarct-related coronary artery; results were evaluated at 30 days. 

997 patients were analyzed, of which 252 (26%) presented in cardiogenic shock and 6.3% had presented cardiorespiratory arrest before PCI. 30 day mortality rate was 57% in patients presenting cardiogenic shock and 11% in those that were stable (RR: 3.74, 95% IC: 2.95 to 4.76 <0.001). Neither balloon angioplasty or the implantation of conventional or drug eluting stents, alter the results of patients that presented in cardiogenic shock.

Conclusion: 

Patients that received PCI to the unprotected left main, had significantly higher 30 day mortality rate when presenting cardiogenic shock at the moment of admission compared to those who were stable. This result was not related to the kind of stent used.

Editorial Comment: 

Although this is a meta analysis, the study shows the evolution of primary PCI to the left main. There are limited available data on this procedure, which differs from the rest of PCI procedures. The intra aortic counterpulsation balloon has not been proved particularly beneficial, though we are still waiting for the ISAR SHOCK 2 outcomes. Sure enough, left ventricular assist devices such as the Impella, TandemHeart, ECMO, or other newer devices, shall facilitate this procedure and provide more benefits to these patients. 

Courtesy of Dr. Carlos Fava.
Interventional Cardiology,
Favaloro Foundation. Buenos Aires, Argentina

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...